Publication | Open Access

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone

Same CombinationMedicineAdditional CoursesMetronomic TherapyBronchial NeoplasmPhase Iii StudyCancer TreatmentOncologyRadiation OncologyLung CancerRadiologyHealth Sciences